BioPharmX to Report Second Quarter Financial Results on September 12, 2016

Tageszeitungen (Symbolbild). pixabay.com

PR Newswire

MENLO PARK, Calif., Sept. 2, 2016

MENLO PARK, Calif., Sept. 2, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on dermatology and women's health, today announced that it will release its financial results for the fiscal second quarter ended July 31, 2016 after the close of trading on Monday, September 12, 2016. The company's management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments.

BioPharmX (BPMX) (PRNewsFoto/BioPharmX Corporation)

Individuals interested in listening to the conference call may do so by dialing (866) 652-5200 for domestic callers or (412) 317-6060 for international callers, and request to join the BioPharmX Corporation call. To listen to a live webcast, please visit the investor relations section of the BioPharmX website at: www.BioPharmX.com.

A replay of the call will be available beginning September 12, 2016 at 4:30pm PT/7:30pm ET through midnight ET on December 12, 2016. To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference Conference ID: 10091989. The webcast will also be available on the BioPharmX website for 90 days following the completion of the call.

About BioPharmX® Corporation
BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, that seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopharmx-to-report-second-quarter-financial-results-on-september-12-2016-300321956.html

SOURCE BioPharmX Corporation

ARIVA.DE Börsen-Geflüster

Kurse

Timber Pharmaceuticals Inc

0,0002 $

+100,0%

Mehr Nachrichten zur Timber Pharmaceuticals Inc Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.